Long Acting Injections and Implants

Chapter 1 An Introduction to Long Acting Injections and Implants

Chapter 2 Historical Overview of Long Acting Injections and Implants

Chapter 3 Host Response to Long Acting Injections and Implants

Chapter 4 Anatomy and Physiology of the Injection Site: Implications for Extended Release Parenteral Systems

Chapter 5 Drugs for Long Acting Injections and Implants

Chapter 6 Diseases and Clinical Applications that Can Benefit from Long Lasting Implants and Injections

Chapter 7 Oily (Lipophilic) Solutions and Suspensions

Chapter 8 Aqueous Suspensions

Chapter 9 In Situ Forming Systems (Depots)

Chapter 10 Microsphere Technologies

Chapter 11 Liposomes as Carriers for Controlled Drug Delivery

Chapter 12 Micro- and Nanoemulsions (Controlled Release Parenteral Drug Delivery Systems)

Chapter 13 Nanosuspensions

Chapter 14 PEGylated Pharmaceutical Nanocarriers

Chapter 15 Protein PEGylation

Chapter 16 Self-Assembling Lipid Formulations

Chapter 17 Implantable Drug Delivery Systems Based on the Principles of Osmosis

Chapter 18 Microtechnologies for Drug Delivery

Chapter 19 Drug-Eluting Stents

Chapter 20 Delivery of Peptides and Proteins via Long Acting Injections and Implants

Chapter 21 Injectable PLGA Systems for Delivery of Vaccine Antigens

Chapter 22 Methods of Sterilization for Controlled Release Injectable and Implantable Preparations

Chapter 23 In Vitro Drug Release Testing and In Vivo/In Vitro Correlation for Long Acting Implants and Injections

Chapter 24 Regulatory Issues and Challenges Associated with the Development of Performance Specifications for Modified Release Parenteral Products